Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Identification of Occupational Exposures in Acute Hematologic Malignancy
- Status
- COMPLETED
- Phase
- N/A
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Status
- RECRUITING
- Phase
- PHASE2
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials
- Status
- TERMINATED
- Phase
- PHASE2
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
- Status
- RECRUITING
- Phase
- N/A
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- N/A